United-Guardian (UG)
NASDAQ:UG
Want to see UG full AI Analyst Report?
Top Page
United-Guardian
(NASDAQ:UG)
Select Model
Select Model
Rating:81Outperform
Price Target:
$8.50
▲(36.66% Upside)
Action:Reiterated
Date:05/16/26
UG scores well primarily due to strong financial quality (debt-free balance sheet and good cash conversion) and compelling valuation (low P/E and high dividend yield). Technicals are supportive but only moderately strong, and inconsistent growth/margin trajectory limits the score from reaching the highest range.
Positive Factors
Debt-free balance sheet
Zero reported debt provides durable financial flexibility: it lowers insolvency risk, preserves capacity to fund operations, dividends or opportunistic M&A, and allows the company to absorb demand shocks over the next several months without reliance on external financing.
Negative Factors
Choppy revenue growth
Irregular top-line performance reduces visibility for planning and constrains reliable growth expectations. Over the medium term this can limit reinvestment, make budgeting for R&D or capacity expansion harder, and leave returns dependent on cyclical personal-care demand.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-free balance sheet
Zero reported debt provides durable financial flexibility: it lowers insolvency risk, preserves capacity to fund operations, dividends or opportunistic M&A, and allows the company to absorb demand shocks over the next several months without reliance on external financing.
Read all positive factors
United-Guardian (UG) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$32.57M
Dividend Yield9.81%
Average Volume (3M)6.29K
Price to Earnings (P/E)9.4
Beta (1Y)0.35
Revenue Growth-4.13%
EPS Growth-18.10%
CountryUS
Employees24
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)0.52
Shares Outstanding4,594,319
10 Day Avg. Volume6,994
30 Day Avg. Volume6,291
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)2.52
Price to Sales (P/S)2.68
P/FCF Ratio14.83
Enterprise Value/Market Cap0.99
Enterprise Value/Revenue2.94
Enterprise Value/Gross Profit6.32
Enterprise Value/Ebitda13.66
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
United-Guardian Business Overview & Revenue Model
Company Description
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LU...
How the Company Makes Money
United-Guardian makes money by selling specialty chemical ingredients to manufacturers and formulators, with revenue primarily generated from product sales. Its key revenue stream is the sale of branded personal care/cosmetic ingredients (e.g., fu...
United-Guardian Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
90
Very Positive
Cash Flow
78
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.94M | 10.55M | 12.18M | 10.89M | 12.70M | 13.93M |
| Gross Profit | 5.10M | 5.03M | 6.46M | 5.41M | 6.70M | 8.18M |
| EBITDA | 2.36M | 2.35M | 3.74M | 2.97M | 4.17M | 5.81M |
| Net Income | 2.36M | 2.11M | 3.25M | 2.58M | 2.57M | 4.66M |
Balance Sheet | ||||||
| Total Assets | 12.70M | 13.11M | 13.80M | 12.92M | 10.64M | 12.24M |
| Cash, Cash Equivalents and Short-Term Investments | 8.04M | 8.57M | 9.40M | 9.09M | 6.48M | 8.17M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.80M | 1.88M | 1.91M | 1.53M | 1.37M | 2.42M |
| Stockholders Equity | 10.90M | 11.23M | 11.88M | 11.39M | 9.27M | 9.82M |
Cash Flow | ||||||
| Free Cash Flow | 2.18M | 1.91M | 3.03M | 2.98M | 2.45M | 5.20M |
| Operating Cash Flow | 2.25M | 1.97M | 3.47M | 3.14M | 2.53M | 5.31M |
| Investing Cash Flow | -473.91K | 175.34K | -7.08M | 4.73M | 897.56K | -183.47K |
| Financing Cash Flow | -2.31M | -2.77M | -2.76M | -459.39K | -3.12M | -5.19M |
United-Guardian Technical Analysis
Positive
6.22
Price Trends
6.77
Positive
6.62
Positive
6.77
Positive
Market Momentum
0.08
Positive
56.40
Neutral
51.85
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UG, the sentiment is Positive. The current price of 6.22 is below the 20-day moving average (MA) of 7.07, below the 50-day MA of 6.77, and below the 200-day MA of 6.77, indicating a bullish trend. The MACD of 0.08 indicates Positive momentum. The RSI at 56.40 is Neutral, neither overbought nor oversold. The STOCH value of 51.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for UG.
United-Guardian Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $32.57M | 9.40 | 21.40% | 9.81% | -4.13% | -18.10% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | $164.65M | 43.41 | 8.21% | 1.48% | 3.78% | -7.26% | |
47 Neutral | $51.27M | -12.70 | -106.32% | ― | -13.98% | 64.53% | |
47 Neutral | $8.55M | ― | 16.79% | ― | ― | ― | |
45 Neutral | $85.52M | -4.31 | -9.41% | ― | -8.16% | 85.14% | |
42 Neutral | $8.53M | 2.93 | -19.54% | ― | -7.51% | -6001.27% |
* Consumer Defensive Sector Average
UG
United-Guardian
7.17
-0.48
-6.23%
ACU
Acme United
42.16
3.86
10.07%
MTEX
Mannatech
4.37
-5.15
-54.10%
SKIN
Beauty Health
0.69
-0.92
-57.33%
GROV
Grove Collaborative Holdings
1.24
-0.19
-13.29%
TKLF
Yoshitsu Co. Ltd. Sponsored ADR
1.95
-1.95
-50.00%
United-Guardian Corporate Events
Executive/Board ChangesShareholder Meetings
United-Guardian Shareholders Reaffirm Board, Pay, and Auditor
Positive
May 15, 2026
At its annual meeting of stockholders held on May 13, 2026, United-Guardian shareholders re-elected all seven director nominees to the board, maintaining continuity in the company’s leadership and governance. Investors also opted to hold say...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.